Health Care Rounds

Hoping all of our listeners had a wonderful and safe Halloween! In this episode, John discusses our take on health care news in the last week of October. He covers President Trump’s proposed change on how Medicare pays for certain drugs, based on an international pricing index of drugs. HHS Secretary Alex Azar referenced a report his agency recently completed—which compared U.S. prices for 27 drugs with prices for the same drugs in 16 other countries—tweeting that “Among these drugs, on average, the US pays 180% more than the international price.” HHS said the rule would include most of the drugs in Medicare Part B, which covers injectables and many specialty medications. About Darwin Research Group Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device compa